Latest News

  • New insights into role of high blood pressure in development of dementia

    For the first time, researchers have identified specific regions of the brain that are damaged by high blood pressure and may contribute to a decline in mental processes and the development of dementia. High blood pressure is known to be involved in causing dementia and damage to brain function. The study, which is published in [...]

  • NeuroRPM receives FDA clearance for Parkinson’s app

    Digital health company, NeuroRPM, has received FDA clearance for its artificial intelligence (AI)-powered remote monitoring app for Parkinson’s disease.  The product uses AI and Apple Watch to continuously and passively monitor bradykinesia, tremor, and dyskinesia, the cardinal symptoms of Parkinson's disease. The product includes advanced, comprehensive monitoring capabilities for Parkinson’s disease available on a wearable [...]

  • Scientists discover new way to fight the ageing process

    New findings could allow experts to improve DNA repair in body cells and target the causes of ageing and cancer development. A protein complex prevents the repair of genome damage in human cells, in mice and in the nematode Caenorhabditis elegans, a team of researchers at the University of Cologne has discovered. They also successfully [...]

  • Age, not weight, should be used to screen for diabetes, says study

    Focus on age, not weight, to capture the greatest number of people in all racial and ethnic groups with prediabetes and diabetes, reports a new study.  Screening all adults aged 35 to 70 years, regardless of weight, identifies the greatest proportion of adults with prediabetes and diabetes in the US, researchers from Northwestern Medicine have [...]

  • New tool to enhance deep brain stimulation for Parkinson’s

    A new spectroscopy probe, with optical fibres to provide real-time information to doctors, could enhance deep brain stimulation procedure for Parkinson’s disease patients. Deep brain stimulation (DBS) has become an increasingly common treatment for patients with advanced Parkinson’s disease, but the procedure still carries significant risks.  A new probe that performs two types of spectroscopy [...]

  • Magnesium helps keep dementia at bay – study

    More magnesium in our daily diet leads to better brain health as we age, according to scientists from The Australian National University (ANU). The researchers say increased intake of magnesium-rich foods such as spinach and nuts could also help reduce the risk of dementia, which is the second leading cause of death in Australia and the seventh [...]

  • Physical exercise helps improve symptoms of Parkinson’s disease

    Physical exercise can help to improve the severity of movement-related symptoms and the quality of life in people with Parkinson’s disease, a new study shows. Findings from the first Cochrane review of the available evidence found that any type of structured exercise is better than none. The review looked at 156 randomised controlled trials comparing [...]

  • New initiative for veterans with cardiovascular disease

    The American Heart Association and Department of Veterans Affairs programme will provide a blueprint for the care of veterans at high risk of cardiovascular events.  More than 2 million veterans are living with atherosclerotic cardiovascular disease (ASCVD) and require management of their high cholesterol, according to the US Department of Veterans Affairs (VA).  Left unaddressed, [...]

  • New insights help spot signs of Alzheimer’s in brain scans

    Researchers from the UK have found that telomere shortening – a sign of cellular ageing – is linked to signs of Alzheimer’s in brain scans. Changes in the brain caused by Alzheimer’s disease are associated with shortening of the telomeres – the protective caps on the ends of chromosomes that shorten as cells age – [...]

  • New focused ultrasound effective for treating Parkinson’s – study

    In a new study researchers show that a new focused ultrasound treatment improved dyskinesia and motor impairment in patients with Parkinson’s disease. Parkinson’s disease is a common neurological disorder characterised by the loss of dopamine neurons in the brain. Patients with Parkinson’s disease can be effectively treated with medications such as levodopa.  However, some patients [...]